Feb 16, 2026
We know that pharmacies buying generics are making a loss when they dispense. Previous analysis, available on the Wavedata.co.uk articles page, shows that over 1200 generic products each month are unprofitable. However, what about parallel imports, are they profitable...
Feb 13, 2026
Charles Joynson, WaveData MD, was delighted to join Jeremy Durrant, Director of Communications and External Engagement at Medicines UK, in the latest episode of their podcast Medicine Matters. It’s a lively discussion, looking at pricing trends over the last 12...
Feb 4, 2026
The House of Lords Public Services Committee has published its report concluding its medicines security inquiry. They argued that it is vital that the UK has strong, resilient medicine supply chains and emphasised the need for clear, proactive leadership. The report...
Jan 30, 2026
Aspirin has been added to the government’s ‘No Export’ list and to the list of concessions meant to help pharmacies break even when they dispense this hard to get product. Prices are rising in the UK market, so we thought we’d have a look at...
Jan 7, 2026
To start the year off with a bang, we thought we’d compare the generic product prices we get from our Pharmacy and Dispensing Doctor data suppliers with the Drug Tariff for each product. This obviously excludes some products where there is no Drug Tariff...
Oct 16, 2025
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus. The average market price for this medicine normally hovers around the £5 mark but in late 2019 the drug tariff started to come down from over £10.42...
